- Home
- LLY
as 01-21-2025 4:00pm EST
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
| Founded: | 1876 | Country: | United States |
| Employees: | N/A | City: | INDIANAPOLIS |
| Market Cap: | 755.9B | IPO Year: | N/A |
| Target Price: | $980.48 | AVG Volume (30 days): | 3.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 22 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 9.25 | EPS Growth: | 67.52 |
| 52 Week Low/High: | $614.82 - $972.53 | Next Earning Date: | 02-06-2025 |
| Revenue: | $40,863,300,000 | Revenue Growth: | 27.41% |
| Revenue Growth (this year): | 34.73% | Revenue Growth (next year): | 28.78% |
Stock Insider Trading Activity of Eli Lilly and Company (LLY)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Zakrowski Donald A | LLY | SVP, Finance, & CAO | Nov 8 '24 | Sell | $803.38 | 900 | $723,042.00 | 5,480 |
Latest Eli Lilly and Company News
LLY Breaking Stock News: Dive into LLY Ticker-Specific Updates for Smart Investing
Barrons.com
11 hours ago
Novo, Lilly Weight-Loss Drugs Reduce Risk of Alzheimer’s, Study Shows. What It Means for the Stocks.
GuruFocus.com
11 hours ago
GLP-1 Drugs Linked to Lower Alzheimer's Risk Amid Safety Warnings
Quartz
14 hours ago
The race for the next Ozempic is on
Insider Monkey
21 hours ago
Is Eli Lilly And Co. (LLY) Splitting in the Near Future?
Zacks
a day ago
NVO Stock Down as Medicare Selects Semaglutide Drugs for Price Cuts
Insider Monkey
2 days ago
Jim Cramer Says ‘Eli Lilly and Company (LLY)’s Drug Is Superior In Terms Of Weight Reduction At The Same Dose’
Insider Monkey
3 days ago
Jim Cramer on Eli Lilly and Company (LLY)’s Q4 2024 Performance: ‘Aren’t As Strong As Wall Street Was Hoping’
Motley Fool
3 days ago
Should You Buy the Dip in Eli Lilly Stock Right Now?
Compare LLY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LLY Eli Lilly and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.